Abstract
Summary
Cyberknife is a stereotactic radiosurgery (SRS) system. It is a non-invasive treatment for cancerous and non-cancerous tumours and other conditions where radiation therapy is indicated. It is used to treat conditions throughout the body, including the prostate, lung, brain, spine, head and neck, liver, pancreas, and kidney, and can be an alternative to surgery or for patients who have inoperable or surgically complex tumours.
The global market for Cyberknife Technology was estimated to be worth US$ 577 million in 2023 and is forecast to a readjusted size of US$ 745 million by 2030 with a CAGR of 4.2% during the forecast period 2024-2030
The rising prevalence of cancer globally is a significant driver for the CyberKnife technology market. CyberKnife, a type of robotic radiosurgery system, offers a non-invasive treatment option for various cancer types, including tumors in the brain, spine, lung, liver, prostate, and other areas that may be challenging to reach with conventional surgery. There is a growing preference for minimally invasive procedures among patients and healthcare providers. CyberKnife technology allows for precise, high-dose radiation delivery to tumors while minimizing damage to surrounding healthy tissue. This non-invasive approach often results in shorter treatment times, fewer side effects, and faster recovery compared to traditional surgery. Continuous advancements in technology have improved the capabilities of CyberKnife systems. These advancements include real-time tumor tracking, image guidance, motion synchronization, and robotic precision. The improved accuracy and flexibility of CyberKnife technology have expanded its applications and made it a preferred treatment option for many cancer patients. Increasing healthcare expenditure, especially in developed economies, is driving the growth of the CyberKnife technology market. The higher investment in healthcare infrastructure, hospitals, and advanced treatment technologies encourages the adoption of innovative therapies like CyberKnife. The availability of favorable reimbursement policies and insurance coverage for CyberKnife treatments has positively influenced the market growth. This encourages healthcare providers to invest in CyberKnife technology and enables patient access to this advanced treatment option. There is a growing awareness and acceptance of CyberKnife technology among patients, healthcare professionals, and medical societies. Extensive research publications, clinical studies, and positive patient outcomes contribute to the increased adoption of CyberKnife technology. While CyberKnife technology involves high initial investment, it can provide long-term cost benefits compared to traditional surgery. By reducing hospital stays, minimizing complications, and improving patient outcomes, CyberKnife treatments have the potential to offer cost savings in the long run.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cyberknife Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cyberknife Technology by region & country, by Type, and by Application.
The Cyberknife Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyberknife Technology.
Market Segmentation
By Company
Accuray Incorporated
BrainLab
Elekta AB
Nucletron B.V.
GE Healthcare
Hitachi America
Mitsubishi Electric
Nordion
Sumitomo Heavy Industries
Varian Medical Systems
Modus Medical Devices Inc.
Koninklijke Philips N.V.
Toshiba Medical Systems Corporation
Shenzhen GeneMDx Biotech. Co., Ltd.
Segment by Type:
Breast Cancer
Prostate Cancer
Brain Cancer
Lung Cancer
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cyberknife Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cyberknife Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cyberknife Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Cyberknife Technology was estimated to be worth US$ 577 million in 2023 and is forecast to a readjusted size of US$ 745 million by 2030 with a CAGR of 4.2% during the forecast period 2024-2030
The rising prevalence of cancer globally is a significant driver for the CyberKnife technology market. CyberKnife, a type of robotic radiosurgery system, offers a non-invasive treatment option for various cancer types, including tumors in the brain, spine, lung, liver, prostate, and other areas that may be challenging to reach with conventional surgery. There is a growing preference for minimally invasive procedures among patients and healthcare providers. CyberKnife technology allows for precise, high-dose radiation delivery to tumors while minimizing damage to surrounding healthy tissue. This non-invasive approach often results in shorter treatment times, fewer side effects, and faster recovery compared to traditional surgery. Continuous advancements in technology have improved the capabilities of CyberKnife systems. These advancements include real-time tumor tracking, image guidance, motion synchronization, and robotic precision. The improved accuracy and flexibility of CyberKnife technology have expanded its applications and made it a preferred treatment option for many cancer patients. Increasing healthcare expenditure, especially in developed economies, is driving the growth of the CyberKnife technology market. The higher investment in healthcare infrastructure, hospitals, and advanced treatment technologies encourages the adoption of innovative therapies like CyberKnife. The availability of favorable reimbursement policies and insurance coverage for CyberKnife treatments has positively influenced the market growth. This encourages healthcare providers to invest in CyberKnife technology and enables patient access to this advanced treatment option. There is a growing awareness and acceptance of CyberKnife technology among patients, healthcare professionals, and medical societies. Extensive research publications, clinical studies, and positive patient outcomes contribute to the increased adoption of CyberKnife technology. While CyberKnife technology involves high initial investment, it can provide long-term cost benefits compared to traditional surgery. By reducing hospital stays, minimizing complications, and improving patient outcomes, CyberKnife treatments have the potential to offer cost savings in the long run.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cyberknife Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Cyberknife Technology by region & country, by Type, and by Application.
The Cyberknife Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyberknife Technology.
Market Segmentation
By Company
Accuray Incorporated
BrainLab
Elekta AB
Nucletron B.V.
GE Healthcare
Hitachi America
Mitsubishi Electric
Nordion
Sumitomo Heavy Industries
Varian Medical Systems
Modus Medical Devices Inc.
Koninklijke Philips N.V.
Toshiba Medical Systems Corporation
Shenzhen GeneMDx Biotech. Co., Ltd.
Segment by Type:
Breast Cancer
Prostate Cancer
Brain Cancer
Lung Cancer
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cyberknife Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Cyberknife Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Cyberknife Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Cyberknife Technology Product Introduction
1.2 Global Cyberknife Technology Market Size Forecast
1.3 Cyberknife Technology Market Trends & Drivers
1.3.1 Cyberknife Technology Industry Trends
1.3.2 Cyberknife Technology Market Drivers & Opportunity
1.3.3 Cyberknife Technology Market Challenges
1.3.4 Cyberknife Technology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cyberknife Technology Players Revenue Ranking (2023)
2.2 Global Cyberknife Technology Revenue by Company (2019-2024)
2.3 Key Companies Cyberknife Technology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Cyberknife Technology Product Offered
2.5 Key Companies Time to Begin Mass Production of Cyberknife Technology
2.6 Cyberknife Technology Market Competitive Analysis
2.6.1 Cyberknife Technology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Cyberknife Technology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyberknife Technology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Breast Cancer
3.1.2 Prostate Cancer
3.1.3 Brain Cancer
3.1.4 Lung Cancer
3.1.5 Others
3.2 Global Cyberknife Technology Sales Value by Type
3.2.1 Global Cyberknife Technology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cyberknife Technology Sales Value, by Type (2019-2030)
3.2.3 Global Cyberknife Technology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Cyberknife Technology Sales Value by Application
4.2.1 Global Cyberknife Technology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cyberknife Technology Sales Value, by Application (2019-2030)
4.2.3 Global Cyberknife Technology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Cyberknife Technology Sales Value by Region
5.1.1 Global Cyberknife Technology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cyberknife Technology Sales Value by Region (2019-2024)
5.1.3 Global Cyberknife Technology Sales Value by Region (2025-2030)
5.1.4 Global Cyberknife Technology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Cyberknife Technology Sales Value, 2019-2030
5.2.2 North America Cyberknife Technology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Cyberknife Technology Sales Value, 2019-2030
5.3.2 Europe Cyberknife Technology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Cyberknife Technology Sales Value, 2019-2030
5.4.2 Asia Pacific Cyberknife Technology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Cyberknife Technology Sales Value, 2019-2030
5.5.2 South America Cyberknife Technology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Cyberknife Technology Sales Value, 2019-2030
5.6.2 Middle East & Africa Cyberknife Technology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cyberknife Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cyberknife Technology Sales Value
6.3 United States
6.3.1 United States Cyberknife Technology Sales Value, 2019-2030
6.3.2 United States Cyberknife Technology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cyberknife Technology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cyberknife Technology Sales Value, 2019-2030
6.4.2 Europe Cyberknife Technology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cyberknife Technology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cyberknife Technology Sales Value, 2019-2030
6.5.2 China Cyberknife Technology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cyberknife Technology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cyberknife Technology Sales Value, 2019-2030
6.6.2 Japan Cyberknife Technology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cyberknife Technology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cyberknife Technology Sales Value, 2019-2030
6.7.2 South Korea Cyberknife Technology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cyberknife Technology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cyberknife Technology Sales Value, 2019-2030
6.8.2 Southeast Asia Cyberknife Technology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cyberknife Technology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cyberknife Technology Sales Value, 2019-2030
6.9.2 India Cyberknife Technology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cyberknife Technology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Accuray Incorporated
7.1.1 Accuray Incorporated Profile
7.1.2 Accuray Incorporated Main Business
7.1.3 Accuray Incorporated Cyberknife Technology Products, Services and Solutions
7.1.4 Accuray Incorporated Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.1.5 Accuray Incorporated Recent Developments
7.2 BrainLab
7.2.1 BrainLab Profile
7.2.2 BrainLab Main Business
7.2.3 BrainLab Cyberknife Technology Products, Services and Solutions
7.2.4 BrainLab Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.2.5 BrainLab Recent Developments
7.3 Elekta AB
7.3.1 Elekta AB Profile
7.3.2 Elekta AB Main Business
7.3.3 Elekta AB Cyberknife Technology Products, Services and Solutions
7.3.4 Elekta AB Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.3.5 Nucletron B.V. Recent Developments
7.4 Nucletron B.V.
7.4.1 Nucletron B.V. Profile
7.4.2 Nucletron B.V. Main Business
7.4.3 Nucletron B.V. Cyberknife Technology Products, Services and Solutions
7.4.4 Nucletron B.V. Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.4.5 Nucletron B.V. Recent Developments
7.5 GE Healthcare
7.5.1 GE Healthcare Profile
7.5.2 GE Healthcare Main Business
7.5.3 GE Healthcare Cyberknife Technology Products, Services and Solutions
7.5.4 GE Healthcare Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.5.5 GE Healthcare Recent Developments
7.6 Hitachi America
7.6.1 Hitachi America Profile
7.6.2 Hitachi America Main Business
7.6.3 Hitachi America Cyberknife Technology Products, Services and Solutions
7.6.4 Hitachi America Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.6.5 Hitachi America Recent Developments
7.7 Mitsubishi Electric
7.7.1 Mitsubishi Electric Profile
7.7.2 Mitsubishi Electric Main Business
7.7.3 Mitsubishi Electric Cyberknife Technology Products, Services and Solutions
7.7.4 Mitsubishi Electric Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.7.5 Mitsubishi Electric Recent Developments
7.8 Nordion
7.8.1 Nordion Profile
7.8.2 Nordion Main Business
7.8.3 Nordion Cyberknife Technology Products, Services and Solutions
7.8.4 Nordion Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.8.5 Nordion Recent Developments
7.9 Sumitomo Heavy Industries
7.9.1 Sumitomo Heavy Industries Profile
7.9.2 Sumitomo Heavy Industries Main Business
7.9.3 Sumitomo Heavy Industries Cyberknife Technology Products, Services and Solutions
7.9.4 Sumitomo Heavy Industries Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.9.5 Sumitomo Heavy Industries Recent Developments
7.10 Varian Medical Systems
7.10.1 Varian Medical Systems Profile
7.10.2 Varian Medical Systems Main Business
7.10.3 Varian Medical Systems Cyberknife Technology Products, Services and Solutions
7.10.4 Varian Medical Systems Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.10.5 Varian Medical Systems Recent Developments
7.11 Modus Medical Devices Inc.
7.11.1 Modus Medical Devices Inc. Profile
7.11.2 Modus Medical Devices Inc. Main Business
7.11.3 Modus Medical Devices Inc. Cyberknife Technology Products, Services and Solutions
7.11.4 Modus Medical Devices Inc. Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.11.5 Modus Medical Devices Inc. Recent Developments
7.12 Koninklijke Philips N.V.
7.12.1 Koninklijke Philips N.V. Profile
7.12.2 Koninklijke Philips N.V. Main Business
7.12.3 Koninklijke Philips N.V. Cyberknife Technology Products, Services and Solutions
7.12.4 Koninklijke Philips N.V. Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.12.5 Koninklijke Philips N.V. Recent Developments
7.13 Toshiba Medical Systems Corporation
7.13.1 Toshiba Medical Systems Corporation Profile
7.13.2 Toshiba Medical Systems Corporation Main Business
7.13.3 Toshiba Medical Systems Corporation Cyberknife Technology Products, Services and Solutions
7.13.4 Toshiba Medical Systems Corporation Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.13.5 Toshiba Medical Systems Corporation Recent Developments
7.14 Shenzhen GeneMDx Biotech. Co., Ltd.
7.14.1 Shenzhen GeneMDx Biotech. Co., Ltd. Profile
7.14.2 Shenzhen GeneMDx Biotech. Co., Ltd. Main Business
7.14.3 Shenzhen GeneMDx Biotech. Co., Ltd. Cyberknife Technology Products, Services and Solutions
7.14.4 Shenzhen GeneMDx Biotech. Co., Ltd. Cyberknife Technology Revenue (US$ Million) & (2019-2024)
7.14.5 Shenzhen GeneMDx Biotech. Co., Ltd. Recent Developments
8 Industry Chain Analysis
8.1 Cyberknife Technology Industrial Chain
8.2 Cyberknife Technology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cyberknife Technology Sales Model
8.5.2 Sales Channel
8.5.3 Cyberknife Technology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer